RETRACTED ARTICLE: lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway
收藏DataCite Commons2026-03-12 更新2024-08-18 收录
下载链接:
https://tandf.figshare.com/articles/dataset/lncNALT_knockdown_ameliorates_hypertensive_retinopathy_via_PTEN_PI3K_AKT_pathway/22714978
下载链接
链接失效反馈官方服务:
资源简介:
We, the Editors and Publisher of the journal Bioengineered, have retracted the following article from publication. Kang, H., Huang, D., Li, H., Deng, X., Liu, S., Gou, W., … Yang, X. (2022). lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway. Bioengineered, 13(7–12), 15003–15012. https://doi.org/10.1080/21655979.2023.2180591 Since publication, significant concerns have been raised by a third party about the integrity of the data and reported results in the article. This includes image duplication with the following article: Zhang, L., Wang, X., Che, W., Yi, Y., Zhou, S., & Feng, Y. (2022). Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression. Bioengineered, 13(6), 14215–14226. https://doi.org/10.1080/21655979.2022.2084494 When approached for an explanation, the authors provided their original data and answered our queries, but these do not sufficiently address the concerns. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed of this decision. We have been informed in our decision-making by our policy on publishing ethics and integrity and COPE guidelines. The retracted article will remain online to maintain the scholarly record and will be digitally watermarked on each page as ‘Retracted’.
《Bioengineered》期刊的编辑与出版方现已撤回下述已发表论文:Kang, H., Huang, D., Li, H., Deng, X., Liu, S., Gou, W. 等及 Yang, X.(2022)。论文题为《lncNALT knockdown通过PTEN/PI3K/AKT通路(PTEN/PI3K/AKT pathway)改善高血压视网膜病变》,发表于*Bioengineered*,13(7–12),15003–15012,DOI: 10.1080/21655979.2023.2180591。该论文发表后,有第三方就其数据完整性与已报道结果的真实性提出重大质疑,其中包括该文与下述论文存在图像重复问题:Zhang, L., Wang, X., Che, W., Yi, Y., Zhou, S. 及 Feng, Y.(2022),论文题为《甲基转移酶样3沉默通过调节脑出血进程中谷胱甘肽过氧化物酶4(glutathione peroxidase 4)水平抑制铁死亡(ferroptosis)进展》,发表于*Bioengineered*,13(6),14215–14226,DOI: 10.1080/21655979.2022.2084494。当编辑部向作者求证解释时,作者提供了原始数据并回应了相关质询,但上述材料不足以充分解决前述质疑。由于验证已发表研究的有效性是维护学术记录完整性的核心要义,因此我方决定撤回该论文,并已将此决定告知所有作者。本次撤稿决策严格遵循我方出版伦理与诚信政策及国际出版伦理委员会(Committee on Publication Ethics, COPE)指南制定。撤稿论文将继续保留在平台以维护学术记录的完整性,并将在每一页添加数字水印,标注"Retracted"。
提供机构:
Taylor & Francis
创建时间:
2023-04-28



